Atrial Fibrillation News

MARLBOROUGH, Mass., April 8, 2024 /--Boston Scientific Corporation (NYSE: BSX) has initiated the NAVIGATE-PF study of the FARAVIEW™ Software Module* when it is used to visualize and track the FARAWAVE™ Nav Pulsed Field Ablation...

Data showing FEops HEARTguide significantly improves efficiency of LAAO procedures presented at the 2024 AF symposium

Final results from inspIRE study demonstrate 80% freedom from atrial arrhythmia recurrence at 12 months in patients with optimal Pulsed Field Ablation applications First look results from admIRE study suggests similar outcomes

The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).

The Heart Rhythm Society (HRS) introduces CardiQ, a digital platform for current, comprehensive, and engaging resources, designed for clinicians seeking to transform care and outcomes for their patients with atrial fibrillation (AFib).

Abelacimab, a Dual-Acting Factor XI / XIa Inhibitor, Demonstrated an Unprecedented Reduction in Bleeding in the Largest and Longest Head-to-Head Study Comparing a Factor XI Inhibitor to a DOAC

Sophia Antipolis – 13 September 2023: Recent advances in the diagnosis and treatment of atrial fibrillation, and what they mean for patients, were considered by a group of around 75 international experts at a three-day meeting that began on...

Benefit may reduce with increased age, according to meta-analysis WASHINGTON (Sep 05, 2023) --The use of direct oral anticoagulants (DOACs) was associated with a reduction in dementia risk compared to traditional blood thinners—like...

Asundexian is an oral inhibitor of Factor XIa that Bayer is developing as a potential treatment for prevention of stroke in atrial fibrillation, as well as for secondary prevention in patients with a non-cardioembolic ischemic stroke...

The American Heart Association’s Getting to the Heart of Stroke™ initiative, developed in conjunction with and supported by HCA Healthcare and the HCA Healthcare Foundation, focuses on preventing, treating and beating stroke by providing...